Carestream receives FDA clearance for figital tomosynthesis

Carestream has received 510(k) clearance from the US Food and Drug Administration for its digital tomosynthesis (DT) functionality.

As an upgradable option on the existing Carestream DRX-Evolution Plus System, the DT technology can simplify workflow and reduce exam time. It will now be available to customers for purchase, and it can be paired with Carestream’s new ImageView Software that is powered by the company’s Eclipse image processing engine. Similar to CT scan, DT can produce cross-sectional images of any organ. However, it uses a single sweep to capture a series of low-dose X-ray images. This functionality will increase visibility for radiologists in time-critical situations.